Patton Fund Management Inc. Acquires New Shares in HCA Healthcare, Inc. $HCA

Key Points

• Patton Fund Management Inc. acquired 671 shares of HCA Healthcare, valued at approximately $257,000 during the second quarter, as reported in their latest 13F filing.
• HCA Healthcare's shares have seen price target adjustments, with JPMorgan raising it from $360 to $370, while Bank of America increased it from $375 to $410, reflecting positive analyst sentiment.
• The company recently announced a quarterly dividend of $0.72 per share, effective September 30, representing a 0.7% yield and a payout ratio of 12.11%.

Patton Fund Management Inc. purchased a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 671 shares of the company's stock, valued at approximately $257,000.

Several other institutional investors and hedge funds have also modified their holdings of the business. Cheviot Value Management LLC bought a new stake in HCA Healthcare in the first quarter valued at about $26,000. Saudi Central Bank acquired a new stake in HCA Healthcare in the first quarter valued at $26,000. WPG Advisers LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter worth about $27,000. Atwood & Palmer Inc. acquired a new stake in shares of HCA Healthcare during the 1st quarter worth about $28,000. Finally, Bartlett & CO. Wealth Management LLC raised its stake in HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on HCA shares. JPMorgan Chase & Co. lifted their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Morgan Stanley cut their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research report on Monday, July 28th. Bank of America boosted their price target on shares of HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a research report on Wednesday, September 10th. Wall Street Zen upgraded shares of HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th. Finally, Wolfe Research downgraded shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research report on Monday, July 28th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $407.75.

Insider Activity

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business's stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Trading Up 1.2%

Shares of HCA Healthcare stock opened at $419.77 on Friday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $422.46. The company has a market cap of $98.22 billion, a price-to-earnings ratio of 17.64, a PEG ratio of 1.32 and a beta of 1.41. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The company's 50-day moving average price is $389.80 and its 200-day moving average price is $369.17.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.